Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical data presented from several GS-9450 studies

April 26, 2010

Nitazoxanide plus PEG-IFN/RBV beneficial in HCV genotype 1

April 26, 2010

PREEMPT trials show benefit of Botox in chronic migraine

April 26, 2010

Tanezumab shows benefit in patients with interstitial cystitis

April 23, 2010

Tacrolimus improves symptoms of bladder pain syndrome/interstitial cystitis

April 23, 2010

Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy

April 23, 2010

BAL-30072 active against beta-lactamase-producing enterobacteria in vivo

April 23, 2010

Cempra presents preclinical and clinical phase I data on CEM-101 antibiotic

April 23, 2010

Clinical data support safety and efficacy of BI-207127 plus PEG-IFN/RBV in HCV genotype 1

April 23, 2010

Pfizer describes new oxazolidinone antibacterial

April 22, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...